The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.
The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...
Chinese platforms have pledged to crack down on hate, but anti-foreigner sentiment still circulates widely online.
Ascentage Pharma (Nasdaq: AAPG) (HKEX: 6855) announced today the pricing of its U.S. initial public offering of 7,325,000 American ...
A global biopharma with a U.S. headquarters in Montgomery County is gearing up to go public on a U.S. exchange.
A Chinese man who injured a Japanese mother and her child and killed a Chinese bus attendant trying to protect them in a knife attack near Shanghai last June has been sentenced to death, according to ...
A Chinese man who injured a Japanese mother and her child and killed a Chinese bus attendant trying to protect them in a knife attack near Shanghai last June has been sentenced to death.
CDMO Joinn Biologics snaps up China biologics plant from Lonza in push to tackle Asia-Pacific market
With the purchase of a former Lonza biologics plant now in the books, San Francisco-based CDMO Joinn Biologics is expanding from one Bay Area to another. | CDMO Joinn Biologics has completed its ...
A Chinese man Thursday was sentenced to death for killing a man in a knife attack near Shanghai last summer. A Japanese mother and her child were also injured on a Japanese school bus in Suzhou, ...
In 2017, weeks after Donald Trump’s first presidential election victory, Xi Jinping became the first Chinese head of state to ...
Ascentage is looking to use the IPO proceeds to advance its Phase III candidates for chronic or small lymphocytic leukemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback